Skip to content

A single-center retrospective study of the prognosis of primary hepatocellular carcinoma treated with radiofrequency assisted hepatectomy

A single-center retrospective study of the prognosis of primary hepatocellular carcinoma treated with radiofrequency assisted hepatectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084147
Enrollment
Unknown
Registered
2024-05-11
Start date
2024-05-15
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

Conventional hepatectomy group (Conventional hepatectomy):None
Radiofrequency assisted hepatectomy group (Radiofrequency assisted hepatectomy):None

Sponsors

The First Affiliated Hospital of PLA Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Age =18 years old. (2) The pathological results showed that the patients with hepatocellular carcinoma were initially treated. (3) Radiofrequency assisted hepatectomy and conventional hepatectomy were performed. (4) Outpatient/inpatient visit record time or telephone follow-up time =1 year. (5) Complete clinical data.

Exclusion criteria

Exclusion criteria: (1) Radiofrequency assisted hepatectomy combined with intraoperative radiofrequency ablation of other lesions or combined perioperative radiofrequency ablation was performed. (2) Radiofrequency assisted hepatectomy combined with palliative treatment for other lesions, such as anhydrous alcohol injection. (3) Patients undergoing liver transplantation after radiofrequency assisted hepatectomy. (4) Patients with a history of liver cancer treatment before surgery, except those who received chemotherapy or Chinese patent drug anti-tumor therapy within 30 days before surgery. (5) Radiofrequency assisted hepatectomy combined with primary malignant tumor resection in other organs, such as hepatopancreaticoduodenectomy, pancreaticocaudectomy combined with partial hepatectomy and nephrectomy. (6) Combined with primary malignant tumors of other organs. (7) Loss of follow-up, such as only one visit; Patients with medical records or telephone follow-up for less than 1 year and no death outcome.

Design outcomes

Primary

MeasureTime frame
To evaluate the safety and efficacy of radiofrequency assisted hepatectomy;

Secondary

MeasureTime frame
To summarize the long-term prognosis of patients with primary HCC treated with radiofrequency assisted hepatectomy;

Countries

China

Contacts

Public ContactKai Feng

The First Affiliated Hospital of PLA Army Medical University

fengkai7688@hotmail.com+86 132 2868 3383

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026